FDA — authorised 7 June 1971
- Marketing authorisation holder: ALRA
- Status: approved
🇺🇸 Azo Gantrisin in United States
FDA authorised Azo Gantrisin on 7 June 1971
Marketing authorisations
FDA — authorised 31 August 1990
- Application: NDA019358
- Marketing authorisation holder: ROCHE
- Local brand name: AZO GANTRISIN
- Indication: TABLET — ORAL
- Status: approved
Azo Gantrisin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Azo Gantrisin approved in United States?
Yes. FDA authorised it on 7 June 1971; FDA authorised it on 31 August 1990.
Who is the marketing authorisation holder for Azo Gantrisin in United States?
ALRA holds the US marketing authorisation.